The global wound dressing market size was valued at USD 13.66 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 4.14% from 2023 to 2030. Rising incidence rate of various wounds such as pressure ulcers, and surgical site wounds, along with rise in number of geriatric population, and increase in traumatic accidents worldwide is expected to impel the wound dressing market.
Chronic wounds such as venous leg ulcers, diabetic foot ulcers are increasing worldwide. For instance, according to NCBI, around 6.5 million people in the U.S. are affected by various chronic wounds. Moreover, rise in diabetic population is further expected to propel the wound dressing market. For instance, as per CDC, in 2018, among the crude population, 34.2 million people in the U.S. have been diagnosed with diabetes, which comprises of around 10.5% of the total U.S. population. Moreover, as per diabeticfootonline.com, up to 34% of the people suffering from diabetes are at a risk of developing a diabetic foot ulcer. Thus, as a result of aforementioned factors, the demand for wound dressing is expected to impel, thereby helping the wound dressing market grow.
Moreover, the geriatric population is more susceptible towards wounds, thus, rising geriatric population is expected to boost the wound dressing market. For instance, according to European Parliament, Japan is the fastest aging country globally, with around 28.7% population aged above 65 years of age. Additionally, as per the similar source, by 2036, it is expected that one third of the Japanese population is projected to be aged above 65 years. Moreover, as per NCBI, ageing can affect wound healing, as a result, geriatric population is expected to require wound dressing to heal wounds, thereby, impelling the wound dressing market.
Furthermore, there has been increase in number of global traumatic accidents. For instance, according to statistics by WHO, every year around 1.2 million people die due to road crashes, whereas, 20 to 50 million people sustain non-fatal injuries. Similarly, as per Economic Times, India witnessed 5,54,796 road accident cases in the year 2020. Such accidents frequently result in significant blood loss and other injuries, necessitating prompt medical response, sometimes requiring surgical procedures to offer patient with instant relief. Thus, rising number of accidents is likely to boost the demand for wound dressing products which is anticipated to lead substantial growth of wound dressing market over forecast duration.
The outbreak of COVID-19 pandemic was expected to lower the use of advanced wound dressing, as they require healthcare advice, thereby restricting the growth of wound dressing market. However, post-pandemic, the wound dressing market is anticipated to grow with a significant growth rate over the forecast duration. This can be attributed to initiatives such as partnership, research and development, geographic expansion, and launch of technologically advanced products by major market players. For instance, in September 2021, Coloplast Corp. inaugurated a factory in Central America, which was intended to support the global growth of company. Similarly, in October 2021, Medline Industries announced an investment of USD 77.5 million to build a new distribution center in Kansas. Thus, due to aforementioned factors, the wound dressing market is expected to boost over the post-pandemic period.
On the basis of product, advanced dressing is expected to dominate the product segment of wound dressing market with a revenue share of 54.36% in 2022. This can be attributed to rising cases of obesity and venous leg ulcers. For instance, as per a study by Sage Journals, the prevalence rate of obesity in India is 40.3%. Similarly, according to WHO, 25.1% of people in Germany are obese. Obese people are more susceptible towards venous leg ulcers, thus, rising obesity among the population is expected to help the advanced dressing segment dominate over the forecast period.
Traditional dressing is expected to witness a considerable CAGR of 3.7% over the forecast period. Traditional dressings are most commonly used to treat burn cases, thus, rising number of burn cases is expected to boost the traditional dressing segment. For instance, according to WHO, on an average 265,000 deaths are caused due to burns every year. Moreover, in India, around 1,000,000 people are moderately or severely burnt each year. Similarly, as per CDC in the U.S. approximately, 4,500 burn victims die annually & 10,000 die due to burn related infections. Thereby, boosting the segment growth.
On the basis of application, chronic wounds segment dominated the wound dressing market with a revenue share of 60.07% in 2022. This can be attributed to increasing incidence of chronic diseases and geriatric population globally. For instance, as per Ageing Asia, in Indonesia, the number of people aged above 60 was 27,524,000 in 2019, which is projected to reach 69,792,000 in 2050. Similarly, there has been increase in number of people suffering from diabetes & diabetic foot ulcers. For instance, as per ScienceDirect, diabetic foot ulcers may affect 25% of the diabetic population & may lead to amputation in around 20% of the infected population. According to American Diabetes Association, in 2018, around 34.2 million people in the U.S. has diabetes, which according to BMC Population Health Metrics is anticipated to triple by 2060. Thus, boosting the segment growth.
The acute wounds segment is projected to witness significant CAGR of 4.2% over the forecast period. This can be accredited to rising number of surgical wounds and surgical site infections worldwide. For instance, as per study by Wound International, the incidence rate of surgical site infections in a general surgery was found to be 11.7%. Similarly, rising incidence of traumatic accidents is expected to impel the segment growth. For instance, as per an article by Brady United Organization, around 316 people in the U.S. are shot every day, leading to acute wounds, which requires wound dressing to heal. Thus, due to above mentioned factors, the wound dressing market is expected to impel over the forecast years.
On the basis of end-use, the hospital segment dominated the wound dressing market with a revenue share of 44.99% in 2022. This can be credited to rising surgical procedures, and increasing number of hospitals. For instance, according to a study published by NCBI in 2020, globally an estimated of 310 million surgical cases are recorded annually, out of which 40 million - 50 million are carried out in the U.S. alone. Moreover, there has been increase in number of hospitals and hospitalization worldwide. For instance, as per the Australian Institute of Health & Welfare, the number of hospitalization in Australia has increased. For instance, in 2019 - 2020, 11.1 million people in Australia were hospitalized. Thus, due to aforementioned factors, the hospital segment is expected to dominate the end-use segment.
However, the home healthcare segment is projected to witness the fastest CAGR of 4.8% during the forecast period. Home healthcare setting have been increasing in many countries. Moreover, many surgeries require prolonged recovery period, leading to frequent changes of wound dressing. Further, geriatric population and bariatric population prefer home healthcare setting. Thus, rising bariatric population & geriatric population is anticipated to boost the home healthcare segment. For instance, as per WHO, the world obesity has tripled since 1975. Additionally, as per similar source, in 2020, wound 39 million children under the age of five were overweight or obese. Thereby, impelling the home healthcare segment over the forecast period.
Based on region, North America dominated the wound dressing market with revenue share of 45.47% in 2022. This dominance can be accredited to well-developed healthcare infrastructure, increasing awareness and presence of major key players in the region. Additionally, increase in number of surgeries in the North America region is expected to impel the wound dressing market. For instance, according to Life Span Organization, approximately 500,000 open heart surgeries were performed in the U.S. in 2018. Similarly, according to AHA Journals, approximately, 40,000 children undergo a congenital heart surgery in the U.S. As such surgeries take time to heal, wound dressing products help in healing these wounds in quick duration. Hence, wound dressing are preferred post-surgery, thereby, impelling the wound dressing market in the North America region.
However, Asia Pacific is estimated to witness fastest CAGR of 4.78% over the forecast period. This can be accredited to rising diabetic population in the region. For instance, according to Down to Earth organization, as of December 2021, India had 74.2 million diabetic populations which was aged between 20 - 79. Moreover, this number is anticipated to increase and reach 124.8 million by 2045. Similarly, according to IDF, in 2019, 3,993,300 people out of the total population of 63,265,700 in Philippines were diabetic. As diabetic people are more prone towards diabetic foot ulcers, therefore, increase in diabetic population may help the wound dressing market grow in the Asia Pacific region.
The wound dressing market is highly fragmented in nature, and have many large and small market players. Competitive rivalry and the degree of competition is expected to be high, which may increase further, as current market players are intensifying their strategies to take a hold on majority of the collagen dressing market. To have a competitive edge over the competitors, many market players are entering into various strategic initiatives such as product launch, mergers and acquisition, and geographic expansion. For instance, in June 2021, MiMedx received regulatory approval from the Japanese Ministry of Health, Labour and Welfare to commercialize their product EPIFIX in Japan. Thus, with various strategies adopted by the market players, the wound dressing market is predicted to impel during the forecast period. Some of the prominent players in the wound dressing market include:
Smith+Nephew
Mölnlycke Health Care AB
Convatec Group PLC
Ethicon (Johnson & Johnson)
URGO
Coloplast Corp.
3M
Integra LifeSciences
PAUL HARTMANN AG
DR.AUSBÜTTEL (DRACO)
Medline Industries, Inc.
Brightwake Ltd.
Report Attribute |
Details |
Market size value in 2023 |
USD 14.20 billion |
Revenue forecast in 2030 |
USD 18.86 billion |
Growth rate |
CAGR of 4.14% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Report updated |
April 2023 |
Quantitative units |
Revenue in USD million and CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, application, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa (MEA) |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; Thailand; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
3M; Coloplast Corp.; Medline Industries; Smith & Nephew; ConvaTec Group PLC; Derma Sciences (Integra LifeSciences); Ethicon (Johnson & Johnson); Baxter International; Molnlycke Health Care AB |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global wound dressing market report on the basis of product, application, end-use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Traditional Dressing
Gauze
Tape
Bandages
Cotton
Others
Advanced Dressing
Moist Dressing
Foam Dressing
Hydrocolloid Dressing
Film Dressing
Alginate Dressing
Hydrogel Dressing
Collagen Dressing
Other Advanced Dressing
Antimicrobial Dressing
Silver Dressing
Non-silver Dressing
Active Dressing
Biomaterials
Skin-substitute
Application Outlook (Revenue, USD Million, 2018 - 2030)
Chronic Wounds
Diabetic Foot Ulcers
Pressure Ulcers
Venous Leg Ulcers
Other Chronic Wounds
Acute Wounds
Surgical & Traumatic Wounds
Burns
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Outpatient Facilities
Home Healthcare
Research & Manufacturing
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
b. The global wound dressing market size was estimated at USD 13.66 billion in 2022 and is expected to reach USD 14.20 billion in 2023.
b. The global wound dressing market is expected to grow at a compound annual growth rate of 4.14% from 2023 to 2030 to reach USD 18.86 billion by 2030.
b. The advanced product segment that comprises moist, antimicrobial, and active products dominated the overall wound dressing market, commanding over 54.47% revenue share in 2022.
b. Some key players operating in the wound dressing market include 3M Healthcare, ColoPlast, Medline Industries, HARTMANN, BSN Medical, Medtronic Plc, Smith & Nephew, ConvaTec, Derma Sciences, and Systagenix.
b. Key factors that are driving the wound dressing market growth include the rising prevalence of conditions such as leg ulcers, venous stasis ulcers, pressure ulcers, and diabetic ulcers, which require lesion management, and are anticipated to boost the global wound dressing market over the forecast period.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
ESOMAR & Great Work to Place Certified
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
The outbreak of the COVID-19 pandemic was expected to lower the use of advanced wound dressing, as they require healthcare advice, thereby restricting the growth of the wound dressing market. However, post-pandemic, the wound dressing market is anticipated to grow at a significant growth rate. The report will account for COVID-19 as a key market contributor.